BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:54:00 AM | Browse: 1004 | Download: 1087
 |
Received |
|
2013-04-25 13:00 |
|
Peer-Review Started |
|
2013-04-25 21:50 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-07-20 22:49 |
|
Revised |
|
|
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-08-20 12:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-08-20 13:34 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-11-08 17:01 |
|
Publish the Manuscript Online |
|
2013-11-11 15:30 |
| Category |
Virology |
| Manuscript Type |
Minireviews |
| Article Title |
Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Paul J Rowan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Paul J Rowan, PhD, MPH, Division of Management, Policy, and Community Health, University of Texas Health Sciences Center at Houston School of Public Health, 1200 Herman Pressler Drive, Houston, TX 77030, United States. prowan@uth.tmc.edu |
| Key Words |
Depression; Therapy; Clinical; Psychiatry |
| Core Tip |
To inform clinical practice, this narrative review summarizes existing evidence regarding the degree that antidepressant prophylaxis boosts hepatitis C antiviral treatment completion compared to a rescue approach. |
| Publish Date |
2013-11-11 15:30 |
| Citation |
Rowan PJ. Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV? World J Virol 2013; 2(4): 139-145 |
| URL |
http://www.wjgnet.com/2220-3249/full/v2/i4/139.htm |
| DOI |
http://dx.doi.org/10.5501/wjv.v2.i4.139 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
